Altasciences

Laval, QC (HQ); Kansas City, MO; Seattle, WA; multiple North American sites · United States

Contract Development & Manufacturinglarge

Specialization: Early phase drug development, preclinical safety, clinical pharmacology (Phase I-II), bioanalysis, formulation/manufacturing

Key Differentiator

UNIQUE hybrid CRO+CDMO model spanning preclinical → Phase IIa

Core Services

Preclinical through Phase IIa (integrated); Bioanalytical; PK/PD; Abuse liability; Clinical pharmacology; GLP toxicology; Formulation development; Manufacturing

Capabilities

Preclinical through Phase IIa (integrated)BioanalyticalPK/PDAbuse liabilityClinical pharmacologyGLP toxicologyFormulation developmentManufacturing

Market Intelligence

UNIQUE hybrid CRO+CDMO model spanning preclinical → Phase IIa. Canadian-headquartered with strong US presence. Seamless early development partner.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.